These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

191 related articles for article (PubMed ID: 32280218)

  • 1. Nanoformulated Bioactive Compounds Derived from Different Natural Products Combat Pancreatic Cancer Cell Proliferation.
    Mousa DS; El-Far AH; Saddiq AA; Sudha T; Mousa SA
    Int J Nanomedicine; 2020; 15():2259-2268. PubMed ID: 32280218
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Ellagic acid inhibits human pancreatic cancer growth in Balb c nude mice.
    Zhao M; Tang SN; Marsh JL; Shankar S; Srivastava RK
    Cancer Lett; 2013 Sep; 337(2):210-7. PubMed ID: 23684930
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Development and characterization of hyaluronic acid modified PLGA based nanoparticles for improved efficacy of cisplatin in solid tumor.
    Alam N; Koul M; Mintoo MJ; Khare V; Gupta R; Rawat N; Sharma PR; Singh SK; Mondhe DM; Gupta PN
    Biomed Pharmacother; 2017 Nov; 95():856-864. PubMed ID: 28903181
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Co-delivery of cisplatin and paclitaxel by folic acid conjugated amphiphilic PEG-PLGA copolymer nanoparticles for the treatment of non-small lung cancer.
    He Z; Huang J; Xu Y; Zhang X; Teng Y; Huang C; Wu Y; Zhang X; Zhang H; Sun W
    Oncotarget; 2015 Dec; 6(39):42150-68. PubMed ID: 26517524
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Co-delivery of sorafenib and metapristone encapsulated by CXCR4-targeted PLGA-PEG nanoparticles overcomes hepatocellular carcinoma resistance to sorafenib.
    Zheng N; Liu W; Li B; Nie H; Liu J; Cheng Y; Wang J; Dong H; Jia L
    J Exp Clin Cancer Res; 2019 May; 38(1):232. PubMed ID: 31151472
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Preferential tumor accumulation and desirable interstitial penetration of poly(lactic-co-glycolic acid) nanoparticles with dual coating of chitosan oligosaccharide and polyethylene glycol-poly(D,L-lactic acid).
    Wang G; Chen Y; Wang P; Wang Y; Hong H; Li Y; Qian J; Yuan Y; Yu B; Liu C
    Acta Biomater; 2016 Jan; 29():248-260. PubMed ID: 26476340
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Mithramycin-loaded mPEG-PLGA nanoparticles exert potent antitumor efficacy against pancreatic carcinoma.
    Liu XJ; Li L; Liu XJ; Li Y; Zhao CY; Wang RQ; Zhen YS
    Int J Nanomedicine; 2017; 12():5255-5269. PubMed ID: 28769562
    [TBL] [Abstract][Full Text] [Related]  

  • 8. CS-PEG decorated PLGA nano-prototype for delivery of bioactive compounds: A novel approach for induction of apoptosis in HepG2 cell line.
    Abd-Rabou AA; Ahmed HH
    Adv Med Sci; 2017 Sep; 62(2):357-367. PubMed ID: 28521254
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Enhanced anticancer activity and oral bioavailability of ellagic acid through encapsulation in biodegradable polymeric nanoparticles.
    Mady FM; Shaker MA
    Int J Nanomedicine; 2017; 12():7405-7417. PubMed ID: 29066891
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Preparation and characterization of PLGA-PEG-PLGA polymeric nanoparticles for co-delivery of 5-Fluorouracil and Chrysin.
    Khaledi S; Jafari S; Hamidi S; Molavi O; Davaran S
    J Biomater Sci Polym Ed; 2020 Jun; 31(9):1107-1126. PubMed ID: 32249693
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Biodegradable double-targeted PTX-mPEG-PLGA nanoparticles for ultrasound contrast enhanced imaging and antitumor therapy in vitro.
    Ma J; Shen M; Xu CS; Sun Y; Duan YR; Du LF
    Oncotarget; 2016 Nov; 7(48):80008-80018. PubMed ID: 27835907
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Evaluation of curcumin loaded chitosan/PEG blended PLGA nanoparticles for effective treatment of pancreatic cancer.
    Arya G; Das M; Sahoo SK
    Biomed Pharmacother; 2018 Jun; 102():555-566. PubMed ID: 29597089
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Ellagic acid encapsulated chitosan nanoparticles for drug delivery system in human oral cancer cell line (KB).
    Arulmozhi V; Pandian K; Mirunalini S
    Colloids Surf B Biointerfaces; 2013 Oct; 110():313-20. PubMed ID: 23732810
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Biodegradable nanoparticles exposing a short anti-FLT1 peptide as antiangiogenic platform to complement docetaxel anticancer activity.
    Conte C; Moret F; Esposito D; Dal Poggetto G; Avitabile C; Ungaro F; Romanelli A; Laurienzo P; Reddi E; Quaglia F
    Mater Sci Eng C Mater Biol Appl; 2019 Sep; 102():876-886. PubMed ID: 31147059
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Enhanced Antitumor Efficacy and Reduced Toxicity of Docetaxel Loaded Estradiol Functionalized Stealth Polymeric Nanoparticles.
    Jain S; Spandana G; Agrawal AK; Kushwah V; Thanki K
    Mol Pharm; 2015 Nov; 12(11):3871-84. PubMed ID: 26375023
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Development of PEGylated PLGA Nanoparticles Co-Loaded with Bioactive Compounds: Potential Anticancer Effect on Breast Cancer Cell Lines.
    Mohammadinejad S; Jafari-Gharabaghlou D; Zarghami N
    Asian Pac J Cancer Prev; 2022 Dec; 23(12):4063-4072. PubMed ID: 36579986
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Enhanced anti-proliferative and pro-apoptotic effects of metformin encapsulated PLGA-PEG nanoparticles on SKOV3 human ovarian carcinoma cells.
    Faramarzi L; Dadashpour M; Sadeghzadeh H; Mahdavi M; Zarghami N
    Artif Cells Nanomed Biotechnol; 2019 Dec; 47(1):737-746. PubMed ID: 30892093
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Biomimetic peptide display from a polymeric nanoparticle surface for targeting and antitumor activity to human triple-negative breast cancer cells.
    Bressler EM; Kim J; Shmueli RB; Mirando AC; Bazzazi H; Lee E; Popel AS; Pandey NB; Green JJ
    J Biomed Mater Res A; 2018 Jun; 106(6):1753-1764. PubMed ID: 29424479
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Development of biodegradable nanoparticles for oral delivery of ellagic acid and evaluation of their antioxidant efficacy against cyclosporine A-induced nephrotoxicity in rats.
    Sonaje K; Italia JL; Sharma G; Bhardwaj V; Tikoo K; Kumar MN
    Pharm Res; 2007 May; 24(5):899-908. PubMed ID: 17377747
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The red wine component ellagic acid induces autophagy and exhibits anti-lung cancer activity in vitro and in vivo.
    Duan J; Zhan JC; Wang GZ; Zhao XC; Huang WD; Zhou GB
    J Cell Mol Med; 2019 Jan; 23(1):143-154. PubMed ID: 30353639
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.